- NCT Number Not Available
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Generic NameGalantamineProduct NameRAZADYNE®Therapeutic AreaBehaviors and Mental DisordersEnrollment% Female62%% WhiteN/A
Product ClassAlzheimer's Disease - Cholinesterase InhibitorsSponsor Protocol NumberGAL-MVD-301Data PartnerJohnson & JohnsonCondition StudiedAlzheimer DiseaseMean/Median Age (Years)N/A
- Protocol with Amendments Available
- Clinical Study Report Available
Please note: Individual-participant level data are not available for this trial. However, the full Clinical Study Report and protocol can be provided.